128,006 Shares in Maze Therapeutics, Inc. $MAZE Acquired by Walleye Capital LLC
MarketBeat
Walleye Capital LLC purchased a new position in Maze Therapeutics, Inc. (NASDAQ:MAZE - Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 128,006 shares of the company's stock, valued at approximately $3,820
NASDAQ:MAZE